
<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/joey/Project/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.4.2-SNAPSHOT" ident="GROBID" when="2017-08-10T23:38+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Databases and ontologies flowCL: ontology-based cell population labelling in flow cytometry</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName>
								<forename type="first">Mé</forename>
								<surname>Lanie Courtot</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Molecular Biology and Biochemistry Department</orgName>
								<orgName type="institution">Simon Fraser University</orgName>
								<address>
									<postCode>V5A 1S6</postCode>
									<settlement>Burnaby</settlement>
									<region>BC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Justin</forename>
								<surname>Meskas</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="laboratory">Terry Fox Laboratory</orgName>
								<orgName type="institution">British Columbia Cancer Agency</orgName>
								<address>
									<postCode>V5Z 1L3</postCode>
									<settlement>Vancouver</settlement>
									<region>BC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Alexander</forename>
								<forename type="middle">D</forename>
								<surname>Diehl</surname>
							</persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">University at Buffalo School of Medicine and Biomedical Sciences</orgName>
								<address>
									<postCode>14203</postCode>
									<settlement>Buffalo</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Radina</forename>
								<surname>Droumeva</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="laboratory">Terry Fox Laboratory</orgName>
								<orgName type="institution">British Columbia Cancer Agency</orgName>
								<address>
									<postCode>V5Z 1L3</postCode>
									<settlement>Vancouver</settlement>
									<region>BC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Raphael</forename>
								<surname>Gottardo</surname>
							</persName>
							<affiliation key="aff3">
								<orgName type="institution">Fred Hutchinson Cancer Research Center</orgName>
								<address>
									<postCode>98109</postCode>
									<settlement>Seattle</settlement>
									<region>WA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Adrin</forename>
								<surname>Jalali</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="laboratory">Terry Fox Laboratory</orgName>
								<orgName type="institution">British Columbia Cancer Agency</orgName>
								<address>
									<postCode>V5Z 1L3</postCode>
									<settlement>Vancouver</settlement>
									<region>BC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Mohammad</forename>
								<forename type="middle">Jafar</forename>
								<surname>Taghiyar</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="laboratory">Terry Fox Laboratory</orgName>
								<orgName type="institution">British Columbia Cancer Agency</orgName>
								<address>
									<postCode>V5Z 1L3</postCode>
									<settlement>Vancouver</settlement>
									<region>BC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Holden</forename>
								<forename type="middle">T</forename>
								<surname>Maecker</surname>
							</persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Institute for Immunity</orgName>
								<orgName type="department" key="dep2">Transplantation and Infection</orgName>
								<orgName type="institution">Stanford University School of Medicine</orgName>
								<address>
									<postCode>94305</postCode>
									<settlement>Stanford</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">J</forename>
								<forename type="middle">Philip</forename>
								<surname>Mccoy</surname>
							</persName>
							<affiliation key="aff5">
								<orgName type="department">Lung and Blood Institute</orgName>
								<orgName type="institution" key="instit1">National Heart</orgName>
								<orgName type="institution" key="instit2">National Institutes of Health</orgName>
								<address>
									<postCode>20892</postCode>
									<settlement>Bethesda</settlement>
									<region>MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Center for Human Immunology, Autoimmunity and Inflammation</orgName>
								<orgName type="institution">National Institutes of Health</orgName>
								<address>
									<postCode>20892</postCode>
									<settlement>Bethesda</settlement>
									<region>MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Alan</forename>
								<surname>Ruttenberg</surname>
							</persName>
							<affiliation key="aff7">
								<orgName type="department">School of Dental Medicine</orgName>
								<orgName type="institution">University at Buffalo</orgName>
								<address>
									<postCode>14214-8006</postCode>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Richard</forename>
								<forename type="middle">H</forename>
								<surname>Scheuermann</surname>
							</persName>
							<affiliation key="aff8">
								<orgName type="institution">Craig Venter Institute</orgName>
								<address>
									<addrLine>La Jolla</addrLine>
									<postCode>92037</postCode>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<postCode>92093</postCode>
									<settlement>San Diego</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Ryan</forename>
								<forename type="middle">R</forename>
								<surname>Brinkman</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="laboratory">Terry Fox Laboratory</orgName>
								<orgName type="institution">British Columbia Cancer Agency</orgName>
								<address>
									<postCode>V5Z 1L3</postCode>
									<settlement>Vancouver</settlement>
									<region>BC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Databases and ontologies flowCL: ontology-based cell population labelling in flow cytometry</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="DOI">10.1093/bioinformatics/btu807</idno>
					<note type="submission">Received on August 29, 2014; revised on November 3, 2014; accepted on December 2, 2014</note>
					<note>*To whom correspondence should be addressed. † The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors. Associate Editor: Jonathan Wren Contact: rbrinkman@bccrc.ca Supplementary information: Supplementary data are available at Bioinformatics online.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
				<p>Motivation: Finding one or more cell populations of interest, such as those correlating to a specific disease, is critical when analysing flow cytometry data. However, labelling of cell populations is not well defined, making it difficult to integrate the output of algorithms to external knowledge sources. Results: We developed flowCL, a software package that performs semantic labelling of cell populations based on their surface markers and applied it to labelling of the Federation of Clinical Immunology Societies Human Immunology Project Consortium lyoplate populations as a use case. Conclusion: By providing automated labelling of cell populations based on their immunopheno-type, flowCL allows for unambiguous and reproducible identification of standardized cell types. Availability and implementation: Code, R script and documentation are available under the Artistic 2.0 license through Bioconductor</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">Introduction</head><p>Both flow cytometry (FCM) and mass cytometry are used to identify one or more cell populations of interest, such as those correlating with a disease phenotype. Cell types can be grouped by their particular combinations of markers, or immunophenotype. Despite progress made towards standardization of FCM assays (<ref type="bibr" target="#b5">Maecker et al., 2012</ref>), the lack of a standard labelling strategy hampers data integration when trying to match gating data resulting from various V C The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com manual or automated tools and heterogeneous sources. The cell ontology (CL) was developed to represent cell types relevant to biology. A recent revision (<ref type="bibr" target="#b3">Diehl et al., 2011</ref>) specifically focused on extending coverage of the CL by improving the representation of haematopoeitic cell types, asserting those cell types in a single-inheritance hierarchy and adding logical restrictions to describe their immunophenotypes. However, multiple issues arose when we attempted to use the CL for labelling of cell types derived from FCM data. The definition of 'mature T cell' (obo:CL_0002419; " obo: " is an abbreviation for http://purl.obolibrary.org/obo/) mentions that it has plasma membrane part some 'T cell receptor complex' (obo:GO_0042101), which itself has part the CD3 marker (obo:PR_000001018), requiring complex reasoning to infer that 'mature T cell' has part some CD3. Additionally, when trying to identify CD3þ cells, FCM experimenters are in fact targeting CD3epsilon (obo:PR_000001020), which is itself a subunit of the CD3 molecule described in the CL. As a consequence, while the CL encompasses information about surface markers, its manual exploitation can be challenging and may require multiple inferences along multiple axes, which is neither optimal nor sustainable with the increase in size of datasets. To address these challenges, we developed flowCL, a software package that enables researchers to unambiguously label their cell populations based on their immunophenotype using the CL. We also improved CL to enhance its utility for automated labelling of cell populations.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">Approach</head><p>The core module of flowCL is an ontology labeller that attempts to provide a semantic identifier to a cell population based on its marker expression profile (i.e., the immunophenotype). The immunophenotype can be identified using either manual or automated methods (<ref type="bibr" target="#b6">Malek et al., 2014;</ref><ref type="bibr" target="#b4">Finak et al., 2014;</ref><ref type="bibr" target="#b7">O'Neill et al., 2014;</ref><ref type="bibr" target="#b8">Qian et al., 2010</ref>). flowCL decomposes a query such as 'CD4þCD8À' (as provided in the conventional format used by immunologists) into its individual markers (CD4, CD8) and translates their relative abundance into a relation used in the CL, such as þ for has plasma membrane part. The steps flowCL takes are as follows: (1) A SPARQL (http://www.w3.org/TR/rdf-sparql-query/) query against the CL fetches the labels and IDs corresponding to the input markers by text matching to the label or synonyms fields in the CL; (2) The marker labels are used to retrieve a list of cell types that contain (or lack) the marker labels; (3) The set of markers that make up each cell type is then retrieved; (4) A final query retrieves all parents up to the root of the CL for each cell type to build a tree diagram of the results.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">Results and discussion</head><p>flowCL was successfully applied to label the cell populations from the Human Immunology Project Consortium (HIPC;<ref type="bibr" target="#b5">Maecker et al., 2012</ref>).<ref type="figure">Figure 1</ref>shows a density dot plot of CD45RA versus CCR7, created by a combination of manual analysis and flowDensity (<ref type="bibr" target="#b6">Malek et al., 2014</ref>). Using flowCL and the immunophenotype 'CD3þCD4þCD8-CCR7-CD45RAþ', an exact match (all markers of the input immunophenotype, along with their specific abundance, correspond to all of the markers that make up the cell type's definition in CL) was returned and the population was labelled 'effector CD4-positive, alpha-beta T cell' (<ref type="figure">Fig. 1</ref>, top left quadrant). The top right quadrant of<ref type="figure">Figure 1</ref>shows where three possible labels are returned when the same specific combination of markers are queried. In this case, flowCL returns all possible matches and computes a ranking score to indicate relevance to the original query. More detail on the flowCL algorithm and results is available in the Supplementary Material. During the development of flowCL, we made several changes to the CL to add synonyms of markers, as well as new restrictions on existing cell types to account for the way they are identified. The current version of flowCL relies on the CL as the ontology source as this is, to the best of our knowledge, the only resource describing cell markers logically for haematopoeitic cell lines. Our code could however be adapted to use another resource; the SPARQL queries are stored in a separate function file from the main code, and only require the URL of a SPARQL endpoint (http://cell.ctde.net:8080/ openrdf-sesame/repositories/CL is used for flowCL) as a parameter.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">Conclusion</head><p>Decoupling the knowledge representation and the software code allows for greater flexibility for extension and updates. As the CL development proceeds, flowCL automatically remains up-to-date with the latest scientific knowledge. Additionally, the information added to the CL is immediately available for the scientific community, independently of the flowCL development or the HIPC project. By providing automated labelling of cell populations based on their immunophenotype, flowCL allows researchers to report results using cell type labels. Future work includes validation on other datasets and extending the CL with an assay-based representation of cell types.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p>This work was supported by National Institutes of Health (NIH)/National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R01 EB008400],<ref type="figure">Fig. 1</ref>. Density dot plot of CD45RA versus CCR7 created using flowDensity and using data from Cambridge Institute for Medical Research, after pre-gating to identify live cells, lymphocytes, CD3þ, CD4þ and CD8À. Each quadrant has the cell labels that were returned by flowCL for each respective cell population, followed by the CL identifier in parentheses and ranking score in square brackets</p></div>
			<note place="foot">Bioinformatics, 31(8), 2015, 1337–1339 doi: 10.1093/bioinformatics/btu807 Advance Access Publication Date: 6 December 2014 Applications Note at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>

			<note place="foot">M.Courtot et al. at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>

			<note place="foot">at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct   xml:id="b0">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="m">Human Immunology Project Consortium (HIPC) [U19 AI089986], Natural Sciences and Engineering Research Council of Canada, National Institute of General Medical Sciences (NIGMS)</title>
		<imprint>
			<biblScope unit="page" from="2" to="3" />
		</imprint>
	</monogr>
	<note>Protein. Ontology) and HHSN272201200028C (ImmPort</note>
</biblStruct>

<biblStruct   xml:id="b1">
	<monogr>
		<title level="m" type="main">Conflict of Interest: None declared</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b2">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">References</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b3">
	<analytic>
		<title level="a" type="main">Hematopoietic cell types: prototype for a revised cell ontology</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">D</forename>
				<surname>Diehl</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biomed. Inf</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="75" to="79" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b4">
	<analytic>
		<title level="a" type="main">OpenCyto: an open source infrastructure for scalable, robust, reproducible, and automated, end-to-end flow cytometry data analysis</title>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Finak</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Comput. Biol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">1003806</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b5">
	<analytic>
		<title level="a" type="main">Standardizing immunophenotyping for the human immunology project</title>
		<author>
			<persName>
				<forename type="first">H</forename>
				<forename type="middle">T</forename>
				<surname>Maecker</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">P</forename>
				<surname>Mccoy</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Nussenblatt</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="191" to="200" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b6">
	<analytic>
		<title level="a" type="main">flowDensity: reproducing manual gating of flow cytometry data by automated density-based cell population identification</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Malek</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="page">677</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b7">
	<analytic>
		<title level="a" type="main">Enhanced flowType/Rchyoptimyx: a bioconductor pipeline for discovery in high-dimensional cytometry data</title>
		<author>
			<persName>
				<forename type="first">O &apos;</forename>
				<surname>Neill</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">K</forename>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1329" to="1330" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b8">
	<analytic>
		<title level="a" type="main">Elucidation of seventeen human peripheral blood b-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data</title>
		<author>
			<persName>
				<forename type="first">Y</forename>
				<surname>Qian</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytometry Part B</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="69" to="82" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>